Showing 1 - 20 results of 21 for search 'C. Genovese', query time: 0.06s
Refine Results
-
1
Book Review: We're Friends, Right? by Jeremy E. C. Genovese
Published 2006-01-01
Article -
2
Physique Correlates with Reproductive Success in an Archival Sample of Delinquent Youth by Jeremy E. C. Genovese
Published 2008-07-01
Article -
3
Piaget, Pedagogy, and Evolutionary Psychology by Jeremy E. C. Genovese
Published 2003-01-01
Article -
4
Book Review: The Power and Limitations of Reinforcement by Jeremy E. C. Genovese
Published 2005-01-01
Article -
5
A Gas-phase Electrochemical Reactor for Carbon Dioxide Reduction back to Liquid Fuels by C. Genovese, C. Ampelli, S. Perathoner, G. Centi
Published 2013-06-01
Article -
6
A Novel Photo-electrochemical Approach for the Chemical Recycling of Carbon Dioxide to Fuels by C. Ampelli, R. Passalacqua, C. Genovese, S. Perathoner, G. Centi
Published 2011-04-01
Article -
7
-
8
-
9
-
10
-
11
The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients... by Robin K. Dore, Jenya N. Antonova, Chakkarin Burudpakdee, Lawrence Chang, Magdaliz Gorritz, Mark C. Genovese
Published 2022-06-01
Article -
12
Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis by Bernard Combe, Proton Rahman, Hideto Kameda, Juan D. Cañete, Gaia Gallo, Noah Agada, Wen Xu, Mark C. Genovese
Published 2020-01-01
Article -
13
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies by Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi
Published 2021-07-01
Article -
14
-
15
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase... by Mark C. Genovese, Roy Fleischmann, Alan Kivitz, Eun-Bong Lee, Hubert van Hoogstraten, Toshio Kimura, Gregory St John, Erin K. Mangan, Gerd R. Burmester
Published 2020-06-01
Article -
16
Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis by Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek, Jeehoon Ghil
Published 2020-08-01
Article -
17
FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension by Mark C. Genovese, Josephine Glover, Maria Greenwald, Wieslawa Porawska, Elias Chalouhi El Khouri, Eva Dokoupilova, Juan Ignacio Vargas, Mykola Stanislavchuk, Herbert Kellner, Elena Baranova, Nobuhito Matsunaga, Rieke Alten
Published 2019-12-01
Article -
18
Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA by Christine Radawski, Mark C. Genovese, Brett Hauber, W. Benjamin Nowell, Kelly Hollis, Carol L. Gaich, Amy M. DeLozier, Kelly Gavigan, Maria Reynolds, Anabela Cardoso, Jeffrey R. Curtis
Published 2019-08-01
Article -
19
Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease by Darlene A. Mitrano, Sam E. Houle, Patrick Pearce, Ricardo M. Quintanilla, Blakely K. Lockhart, Benjamin C. Genovese, Rachel A. Schendzielos, Emma E. Croushore, Ethan M. Dymond, James W. Bogenpohl, Harold J. Grau, Lisa Smith Webb
Published 2021-06-01
Article -
20
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study by Mark C. Genovese, Maria W. Greenwald, Sergio R. Gutierrez-Ureña, Mario H. Cardiel, Jeffrey E. Poiley, Anna Zubrzycka-Sienkiewicz, Christine E. Codding, Annie Wang, Weizhong He, Rebecca Amos, Raul Vinueza, Xuegong Wang, Jay P. Garg, Alan J. Kivitz
Published 2019-08-01
Article